Moxley, R.A.;                     Francis, D.H.;                     Tamura, M.;                     Marx, D.B.;                     Santiago-Mateo, K.;                     Zhao, M.    
        Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model. Toxins 2017, 9, 49.
    https://doi.org/10.3390/toxins9020049
    AMA Style
    
                                Moxley RA,                                 Francis DH,                                 Tamura M,                                 Marx DB,                                 Santiago-Mateo K,                                 Zhao M.        
                Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model. Toxins. 2017; 9(2):49.
        https://doi.org/10.3390/toxins9020049
    
    Chicago/Turabian Style
    
                                Moxley, Rodney A.,                                 David H. Francis,                                 Mizuho Tamura,                                 David B. Marx,                                 Kristina Santiago-Mateo,                                 and Mojun Zhao.        
                2017. "Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model" Toxins 9, no. 2: 49.
        https://doi.org/10.3390/toxins9020049
    
    APA Style
    
                                Moxley, R. A.,                                 Francis, D. H.,                                 Tamura, M.,                                 Marx, D. B.,                                 Santiago-Mateo, K.,                                 & Zhao, M.        
        
        (2017). Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model. Toxins, 9(2), 49.
        https://doi.org/10.3390/toxins9020049